Enveric Biosciences (ENVB) EBT Margin Growth (5y) (2019 - 2020)

Enveric Biosciences (ENVB) EBT Margin Growth (5y) (2019 - 2020) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	138.60 Bn	130.75 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.93 Bn	77.93 Bn	3.93 Bn
3	Argenx Se	65.06 Bn	59.88 Bn	1.37 Bn
4	Moderna	56.22 Bn	51.08 Bn	52.00 Mn
5	BeOne Medicines	42.03 Bn	36.93 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.65 Bn	28.34 Bn	992.69 Mn
7	BioNTech SE	27.70 Bn	9.31 Bn	668.28 Mn
8	Insmed	27.48 Bn	26.32 Bn	358.27 Mn
9	Royalty Pharma	27.31 Bn	26.48 Bn	-
10	Enveric Biosciences	5.58 Mn	-2.71 Mn	-

Download Data